ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 109.60
+6.20 (6.00%)
At close: Jan 7, 2026
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €8.05 billion as of January 7, 2026. Its market cap has increased by 1,694.66% in one year.
Market Cap
8.05B
Enterprise Value
7.53B
Revenue
5.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€109.60
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 8.05B, an increase of 3,881.56%. That is a compound annual growth rate of 41.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 8.05B | -14.12% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 121.47B |
| Sanofi | 100.17B |
| Sartorius Stedim Biotech | 20.86B |
| bioMérieux | 13.25B |
| Eurofins Scientific SE | 11.88B |
| Ipsen | 9.61B |
| Virbac | 2.96B |
| emeis Société anonyme | 2.26B |